Review



droplet microarray dma slides  (Aquarray GmbH)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Aquarray GmbH droplet microarray dma slides
    Droplet Microarray Dma Slides, supplied by Aquarray GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/droplet+microarray+dma+slides/droplet+microarray/pm37981010-231-1-8
    Average 90 stars, based on 1 article reviews
    droplet microarray dma slides - by Bioz Stars, 2026-11
    90/100 stars

    Images

    Related Articles

    Microarray:

    Article Title: ANDeS: An automated nanoliter droplet selection and collection device.
    Article Snippet: The movement from the start point to the end point and vice versa was measured with a Mitutoyo 530–122 vernier caliper with a resolution of 0.02 mm (Mitutoyo, Kawasaki, Japan). .. The droplet microarray DMA slides were purchased from Aquarray GmbH, Eggenstein-Leopoldshafen, Germany. .. All the steps of automatic droplet printing were carried out using a universal liquid dispenser (IDOT, Dispendix GmbH, Germany).



    Similar Products

    droplet microarray dma slides  (Aquarray GmbH)
    90
    Aquarray GmbH droplet microarray dma slides
    Droplet Microarray Dma Slides, supplied by Aquarray GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/droplet+microarray+dma+slides/droplet+microarray/pm37981010-231-1-8
    Average 90 stars, based on 1 article reviews
    droplet microarray dma slides - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    droplet microarray (dma) slides  (Aquarray GmbH)
    90
    Aquarray GmbH droplet microarray (dma) slides
    Workflow for high‐throughput drug screening and hit validation. The droplet <t>microarray</t> chip uses minimal reagents (200 nL medium, 300 cells per spot) to screen 2208 FDA‐approved drugs rapidly and economically. The assay is validated using MTT assays in a standard 96‐well plate. On‐ and off‐target effects are assessed using Western blot and mass spectrometry. Drug target analysis is correlated with patient survival data from the Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA) databases to facilitate personalized clinical treatment.
    Droplet Microarray (Dma) Slides, supplied by Aquarray GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/droplet+microarray+dma+slides/droplet+microarray/pmc11469062-181-1-8
    Average 90 stars, based on 1 article reviews
    droplet microarray (dma) slides - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    droplet-microarray (dma) slides (1 × spots)  (Aquarray GmbH)
    90
    Aquarray GmbH droplet-microarray (dma) slides (1 × spots)
    Workflow for high‐throughput drug screening and hit validation. The droplet <t>microarray</t> chip uses minimal reagents (200 nL medium, 300 cells per spot) to screen 2208 FDA‐approved drugs rapidly and economically. The assay is validated using MTT assays in a standard 96‐well plate. On‐ and off‐target effects are assessed using Western blot and mass spectrometry. Drug target analysis is correlated with patient survival data from the Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA) databases to facilitate personalized clinical treatment.
    Droplet Microarray (Dma) Slides (1 × Spots), supplied by Aquarray GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/droplet+microarray+dma+slides/droplet+microarray/pm33325613-172-1-13
    Average 90 stars, based on 1 article reviews
    droplet-microarray (dma) slides (1 × spots) - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    droplet-microarray (dma) slides × spots  (Aquarray GmbH)
    90
    Aquarray GmbH droplet-microarray (dma) slides × spots
    Workflow for high‐throughput drug screening and hit validation. The droplet <t>microarray</t> chip uses minimal reagents (200 nL medium, 300 cells per spot) to screen 2208 FDA‐approved drugs rapidly and economically. The assay is validated using MTT assays in a standard 96‐well plate. On‐ and off‐target effects are assessed using Western blot and mass spectrometry. Drug target analysis is correlated with patient survival data from the Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA) databases to facilitate personalized clinical treatment.
    Droplet Microarray (Dma) Slides × Spots, supplied by Aquarray GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/droplet+microarray+dma+slides/droplet+microarray/pmc11469186-9-0-12
    Average 90 stars, based on 1 article reviews
    droplet-microarray (dma) slides × spots - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Workflow for high‐throughput drug screening and hit validation. The droplet microarray chip uses minimal reagents (200 nL medium, 300 cells per spot) to screen 2208 FDA‐approved drugs rapidly and economically. The assay is validated using MTT assays in a standard 96‐well plate. On‐ and off‐target effects are assessed using Western blot and mass spectrometry. Drug target analysis is correlated with patient survival data from the Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA) databases to facilitate personalized clinical treatment.

    Journal: Advanced Healthcare Materials

    Article Title: Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip

    doi: 10.1002/adhm.202300591

    Figure Lengend Snippet: Workflow for high‐throughput drug screening and hit validation. The droplet microarray chip uses minimal reagents (200 nL medium, 300 cells per spot) to screen 2208 FDA‐approved drugs rapidly and economically. The assay is validated using MTT assays in a standard 96‐well plate. On‐ and off‐target effects are assessed using Western blot and mass spectrometry. Drug target analysis is correlated with patient survival data from the Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA) databases to facilitate personalized clinical treatment.

    Article Snippet: The droplet microarray (DMA) slides were purchased from Aquarray GmbH (catalog, IR0050241542, Eggenstein‐Leopoldshafen, Germany).

    Techniques: High Throughput Screening Assay, Drug discovery, Biomarker Discovery, Microarray, Western Blot, Mass Spectrometry